Corazon (Corsee) D. Sanders, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 4,810 shares at $37.39 ($180K) on 2025-06-20, disclosed to the SEC on 2025-06-23.
Scheduled sale ($180k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.39 | 2,405 | $90K | 50.0% |
| 2 | $37.39 | 2,405 | $90K | 50.0% |
| Total | $37.39 avg | 4,810 | $180K | 100% |
| Filing → |
| ONC | SELL | 2025-12-01 | $1.8M | — | Filing → |
| ONC | SELL | 2025-09-09 | $898K | — | Filing → |
| RARE | SELL | 2024-07-03 | $24K | — | Filing → |